Clinical Trials Logo

Filter by:
NCT ID: NCT02543333 Completed - Asthma Clinical Trials

Validation of Structured Light Plethysmography: Asthma

SLPBD
Start date: July 2013
Phase:
Study type: Observational

Validation of Structured Light Plethysmography (SLP) in patients with asthma, in patients with acute asthma; an observational study in healthy participants and during patients' clinical investigation of broncho-reversibility in the asthma groups.

NCT ID: NCT02543021 Completed - Clinical trials for Inflammatory Bowel Disease

Virtual Chromoendoscopy for Colitis Surveillance: A Feasibility Study

Start date: November 1, 2015
Phase: N/A
Study type: Interventional

Patients with colitis require regular 'surveillance' colonoscopy as their risk of developing colon cancer is at least 2.5 times that of the general population. However, cancer in colitis develops as flat lesions called dysplasia, that can be easily missed at routine colonoscopy. As a result NICE guidelines for colitis surveillance recommend the use of a technique called chromoendoscopy (CE) in which a water-soluble blue dye is sprayed through the colonoscope to coat and highlight the lining of the bowel, making dysplasia easier to see. Although CE is accepted as best practice for surveillance it is time-consuming, technically difficult and requires expertise to interpret the appearances. For these reasons, its use is not widespread and the vast majority of patients still receive the inferior 'routine' colonoscopy without CE. New technology means that the video image obtained during colonoscopy can be digitally enhanced and coloured at the press of a button - termed virtual chromoendoscopy (VCE). This could make surveillance colonoscopy shorter, more comfortable and cleaner (resulting in a more 'dignified' experience) as well as cheaper and less technically difficult. The main objectives to be explored in this feasibility study (and the larger trial) were informed by a PPI meeting, which placed the ability to detect dysplasia at equal importance with the participant's experience of the procedure in terms of speed, comfort and dignity. This is primarily a feasibility study to assess patient experience, recruitment and retention rates to the investigators' specified trial design, to support the development of a larger crossover trial to compare VCE to CE during surveillance colonoscopy for colitis.

NCT ID: NCT02542813 Completed - Clinical trials for Postpartum Hemorrhage

Safety, Tolerability and Pharmacokinetics (PK) Study of Oxytocin (GR121619) Administered Via an Inhaled Route in Healthy Female Volunteers

Start date: September 14, 2015
Phase: Phase 1
Study type: Interventional

Intramuscular (IM) oxytocin is the gold standard prophylactic therapy for post partum haemorrhage (PPH). However, in resource-poor settings within the developing world, the stability and therefore effectiveness of prophylactic IM oxytocin is diminished by a lack of appropriate refrigeration facilities and availability of trained health care professionals (HCPs) to administer IM injections. This study will be the first investigation of oxytocin in humans via the inhaled (IH) route and is designed to evaluate the safety and tolerability of inhaled oxytocin and the five non-pharmacologically active components in the placebo, and to establish the PK characteristics of up to four fixed escalating doses of inhaled oxytocin. In this single blind ascending dose-escalation study, the systemic exposure from up to four proposed escalating inhaled fixed-dose levels (50 micrograms [mcg], 200 mcg, 400 mcg and 600 mcg) will be compared with the systemic exposure following 10 international units (IU) of IM oxytocin in healthy premenopausal females.. A total of 15 subjects will be enrolled after screening sufficient number of healthy female subjects and the subjects will be assigned to one of the two treatment sequences. The total duration of this study is approximately 20 weeks.

NCT ID: NCT02542787 Completed - Clinical trials for Spasticity in People With Multiple Sclerosis

Study of VSN16R for the Treatment of Spasticity in Multiple Sclerosis

Start date: August 2015
Phase: Phase 2
Study type: Interventional

Phase II a Proof of concept study in Multiple Sclerosis (MS) patients with spasticity.

NCT ID: NCT02542696 Completed - Parkinson Disease Clinical Trials

Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

Start date: August 31, 2015
Phase: Phase 3
Study type: Interventional

An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

NCT ID: NCT02542631 Completed - Clinical trials for Diabetes Mellitus, Type 2

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients

Start date: August 1, 2015
Phase: N/A
Study type: Interventional

To compare glycemic control and treatment satisfaction using a novel bolus insulin patch (Finesse) versus a pen for initiating and managing bolus insulin dosing in patients with T2DM not achieving glycemic targets on basal insulin with/without anti-hyperglycemic agents.

NCT ID: NCT02542488 Completed - Pregnancy Clinical Trials

STOPBANG As A Screening Tool for Obstructive Sleep Apnoea in Pregnancy

Start date: February 2, 2016
Phase:
Study type: Observational

This study evaluates the use of the STOPBANG questionnaire to predict whether a pregnant woman with class III obesity has obstructive sleep apnoea. All participants will have a STOPBANG score and modified STOPBANG score (substituting Epworth score > 10 with the tired item) calculated and then be tested with overnight pulse oximetry to see if they meet ODI criteria for obstructive sleep apnoea.

NCT ID: NCT02542254 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

The Effects of RPL554 on Top of Standard COPD Reliever Medications

Start date: October 2015
Phase: Phase 2
Study type: Interventional

This study evaluates the addition of RPL554 to standard reliever medications for chronic obstructive pulmonary disorder (COPD). All patients will receive the same six treatments in a randomised sequence: 1. salbutamol, 2. ipratropium, 3. salbutamol + RPL554, 4. ipratropium + RPL554, 5. RPL554 6. Placebo

NCT ID: NCT02542072 Completed - Myopia Clinical Trials

Multi-Center Clinical Evaluation of Two Reusable Soft Contact Lenses

Start date: August 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the subjective performance of comfilcon A lens against samfilcon A lens after 4 weeks of reusable lens wear.

NCT ID: NCT02541266 Completed - Cancer Clinical Trials

Imaging in Clinical Trials - a Questionnaire Study to Assess Impact of Imaging Regimes on Patient Participation

ASK
Start date: April 1, 2015
Phase:
Study type: Observational

This research is aimed at finding out what may influence the decision of patients to participate in trials involving imaging so that the investigators may improve our future studies so they are more patient focused and acceptable in regards to scan schedules.